Hohimer Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.17M | Sell |
|
|||||
|
2025
Q2 | $2.54M | Sell |
|
|||||
|
2025
Q1 | $2.67M | Sell |
|
|||||
|
2024
Q4 | $2.96M | Buy |
|
|||||
|
2024
Q3 | $2.45M | Hold |
|
|||||
|
2024
Q2 | $2.59M | Buy |
|
|||||
|
2024
Q1 | $317K | Hold |
|
|||||
|
2023
Q4 | $536K | Hold |
|
|||||
|
2023
Q3 | $357K | Sell |
|
|||||
|
2023
Q2 | $428K | Sell |
|
|||||
|
2023
Q1 | $381K | Hold |
|
|||||
|
2022
Q4 | $323K | Buy |
|
|||||
|
2022
Q3 | $262K | Sell |
|
|||||
|
2022
Q2 | $233K | Hold |
|
|||||
|
2022
Q1 | $400K | Hold |
|
|||||
|
2021
Q4 | $385K | Hold |
|
|||||
|
2021
Q3 | $274K | Buy |
|
|||||
|
2021
Q2 | $355K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $207K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $309K | Buy |
|
|||||
|
2020
Q1 | $201K | Sell |
|
|||||
|
2019
Q4 | $550K | Buy |
|